Pathogenic mechanisms in the rheumatoid nodule: Comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1783-1797

  Wikaningrum, R ^a   Highton, J ^a   Parker, A ^b   Coleman, M ^b   Hessian, P A ^a   Roberts Thomson, P J ^c   Ahern, M J ^d   Smith, M D ^b,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CORRELATION FUNCTION; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID NODULE; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RHEUMATOID NODULE; RNA, MESSENGER; SIALOGLYCOPROTEINS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031668992     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1783::AID-ART10>3.0.CO;2-W     Document Type: Article

References (50)

1. Highton J, Theewis W, Palmer DG. Characteristics of patients with rheumatoid arthritis attending the Dunedin rheumatology clinic. Proc Univ Otago Med Sch 1982;60:4-6.
2. Matteson EL, Cohen MD, Conn DL. Rheumatoid arthritis: clinical features - systemic involvement. In: Klippel JH, Dieppe PA, editors. Rheumatology. Mosby Year Book, Europe; 1994. p. 5.1-5.8.
3. Ziff M. The rheumatoid nodule. Arthritis Rheum 1990;33:761-7.
4. Palmer DG, Hogg N, Highton J, Hessian PA, Denholm I. Macrophage migration and maturation within rheumatoid nodules. Arthritis Rheum 1987;30:729-36.
5. Hedfors E, Klareskog L, Lindblad S, Forsum U, Lindahl G. Phenotypic characterization of cells within subcutaneous rheumatoid nodules. Arthritis Rheum 1983;26:1333-9.
6. Duke OL, Hobbs S, Panayi GS, Poulter LW, Rasker JJ, Janossy G. A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule. Clin Exp Immunol 1984;86:239-46.
7. Athanasou NA, Quinn J, Woods CG, McGee JOD. Immunohistology of rheumatoid nodules and rheumatoid synovium. Ann Rheum Dis 1988;47:398-403.
8. 2+-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993;53:197-204.
9. Palmer DG, Hogg N, Allen CA, Highton J, Hessian PA. A mononuclear phagocyte subset associated with cell necrosis in rheumatoid nodules: identification with monoclonal antibody 5.5. Clin Immunol Immunopathol 1987;45:17-28.
10. Highton J, Palmer DG, Smith M, Hessian PA. Phenotypic markers of lymphocyte and mononuclear phagocyte activation within rheumatoid nodules. J Rheumatol 1990;17:1130-6.
11. De Keyser F, Verbruggen G, Veys EM, Cavelier C, Malfait A-M, Benoit G, et al. T cell receptor Vβ usage in rheumatoid nodules: marked oligoclonality among IL-2 expanded lymphocytes. Clin Immunol Immunopathol 1993;68:29-34.
12. Mojcik CF, Shevach EM. Adhesion molecules: a rheumatologic perspective. Arthritis Rheum 1997;40:991-1004.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Smith MD, Chandran G, Youssef PP, Darby T, Ahern MJ. Day case knee arthroscopy under regional anaesthesia, performed by rheumatologists. Aust N Z J Med 1996;26:108-9.
15. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 1992;35:874-83.
16. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, et al. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 1997; 40:1400-8.
17. Smith MD, O'Donell J, Highton J, Palmer DG, Rosenbilds M, Roberts-Thomson PJ. Immunohistochemical analysis of synovial membranes from inflammatory and noninflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 1992;24:19-26.
18. Youssef PP, Triantafillou S, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ, et al. Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis: reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis Rheum 1996;39:1970-9.
19. Smith MD, Triantafillou S, Parker A. Coleman M. A nonradioactive method of in situ hybridisation which utilises riboprobes and paraffin-embedded tissue and its combination with immunohistochemistry. Diagn Mol Pathol 1997;6:34-41.
20. Youssef PP, Triantafillou S, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ, et al. Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using colour video image analysis. J Rheumatol 1997;24:2291-8.
21. Koch AE, Burrows JC, Haines GK, Carlos TM, Harlan JM, Leibovich SJ. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab Invest 1991;64:313-20.
22. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.
23. Soden M, Rooney M, Whelan A, Feighery C, Bresnihan B. Immunohistological analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis. Ann Rheum Dis 1991;50:673-6.
24. Miyasaka N, Sato K, Yamamoto K, Goto M, Nishioka K. Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis 1989;48:220-6.
25. Miyasaka N, Saito I, Uemura T, Kashiwazaki S. Augmented expression of inflammatory cytokines and adhesion molecules in accelerated nodulosis during methotrexate therapy [letter]. Ann Rheum Dis 1994;53:480-1.
26. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
27. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
28. Bazzoni F, Beutler B. The tumour necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
29. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
30. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
31. Sugiyama M, Tzukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwashaki K. Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996;55:442-9.
32. Highton J, Smith M, Bradley J. Cells of the monocyte-macrophage series in peripheral blood and synovial fluid in inflammatory arthritis: a preliminary study of cellular phenotype. Scand J Rheumatol 1989;18:393-8.
33. Shinohora S, Hirohata S, Inoue T, Ito K. Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritis. J Rheumatol 1992;19:211-5.
34. Highton J, Carlisle B, Palmer DG. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 1995;102:541-6.
35. Goto M, Fujisawa M, Yamada Y, Okabe T, Takaku F, Sasame M, et al. Spontaneous release of angiotensin converting enzyme and interleukin-1β from peripheral blood monocytes from patients with rheumatoid arthritis under serum free conditions. Ann Rheum Dis 1990;49:172-6.
36. Hahu G, Stuhlmuller B, Hain N, Kalden JR, Pfizenmeier K, Burmester GR. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapharesis therapy. J Clin Invest 1993;91:862-70.
37. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
38. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, et al. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 1992;149:1054-62.
39. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5.
40. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, et al. Localization of interleukin-1α, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 1992;31:801-9.
41. Koch AE, Kunkel SE, Chensue SW, Haines GK, Strieter RM. Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 1992;65:23-9.
42. Wood NC, Dickens JA, Symons JA, Duff GW. In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. Clin Immunol Immunopathol 1992;62:295-300.
43. Bendrups A, Hilton A, Maeger A, Hamilton JA. Reduction of tumor necrosis factor α and interleukin-1β levels in human synovial tissue by interleukin-4 and glucocorticoid. Rheumatol Int 1993;12:217-20.
44. Kerstens PJSM, Boerbooms AMT, Jeurissen MEC, Fast JH, Assmann KJM, van de Putte LBA. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis: an analysis of ten cases. J Rheumatol 1992;19:867-71.
45. 2 fragment of anti-E-selectin monoclonal antibody. Radiology 1995;194:843-50.
46. Edwards JCW, Wilkinson LS, Pitsillides AA. Palisading cells of rheumatoid nodules: comparison with synovial intimal cells. Ann Rheum Dis 1993;52:801-5.
47. Wilkinson LS, Edwards JCW, Poston RN, Haskard DO. Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab Invest 1993;68:82-8.
48. Kriegsmann JG, Keyszer M, Geiler T, Brauer R, Gay RE, Gay S. Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 1995;72:209-14.
49. Hemler ME, Elices MJ, Parker C, Takada Y. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 1990;114:45-65.
50. Postigo AA, Garcia-Vicuna R, Diaz-Gonzalez F, Arroyo AG, Landazuri MO, Chi-Rosso G, et al. Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). J Clin Invest 1992;89:1445-52.